ACELINK THERAPEUTICS Trademark

Trademark Overview


On Friday, February 18, 2022, a trademark application was filed for ACELINK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ACELINK THERAPEUTICS trademark a serial number of 97273549. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, June 12, 2024. This trademark is owned by ACELINK THERAPEUTICS, INC.. The ACELINK THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for the prevention and treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for treating glycolipid storage diseases, diseases associated with glycolipid accumulation
acelink therapeutics

General Information


Serial Number97273549
Word MarkACELINK THERAPEUTICS
Filing DateFriday, February 18, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, June 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical products for the prevention and treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for treating glycolipid storage diseases, diseases associated with glycolipid accumulation
Pseudo MarkACE LINK THERAPEUTICS
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameACELINK THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Party NameACELINK THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewark, CA 94560

Trademark Events


Event DateEvent Description
Tuesday, February 22, 2022NEW APPLICATION ENTERED
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, December 4, 2022ASSIGNED TO EXAMINER
Monday, December 12, 2022NON-FINAL ACTION WRITTEN
Monday, December 12, 2022NON-FINAL ACTION E-MAILED
Monday, December 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 1 FILED
Wednesday, December 13, 2023SOU EXTENSION 1 GRANTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU EXTENSION 2 FILED
Thursday, June 13, 2024SOU EXTENSION 2 GRANTED